National Drug Authority

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Pontificia Universidad Javeriana哥伦比亚4
2. United States Pharmacopeial Convention美国2
3. Pharmacy and Poisons Board肯尼亚2
4. Food and Drugs Authority加纳2
5. Makerere University乌干达2
6. Kenyatta National Hospital肯尼亚2
7. October University of Modern Sciences and Arts埃及2
8. UCLouvain比利时2

按月发文

逐年被引

最新文献

1. 1
   Correction: Advancing Pharmacovigilance Practice in Africa: Moving from Data Collection to Data-Driven Decision Making—Report from the 4th ISoP Africa Chapter MeetingDrug Safety20261
2. 2
   Advancing Pharmacovigilance Practice in Africa: Moving from Data Collection to Data-Driven Decision Making—Report from the 4th ISoP Africa Chapter MeetingDrug Safety20253
3. 3
   The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs)Drug Safety20235
4. 4
   Drug safety in Africa: a review of systems and resources for pharmacovigilanceExpert Opinion on Drug Safety202321
5. 5
   The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is NeededDrug Safety202313
6. 6
   Facilitators and Barriers to Uptake of the Med Safety Mobile App for Adverse Drug Reaction Reporting by Health Workers in Uganda: A Qualitative StudyDrug Safety202319
7. 7
   The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up StudyDrug Safety201829
8. 8
   Targeted Spontaneous Reporting of Suspected Renal Toxicity in Patients Undergoing Highly Active Anti-Retroviral Therapy in Two Public Health Facilities in UgandaDrug Safety201523

高被引文献

1. 1
   The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up StudyDrug Safety201829
2. 2
   Targeted Spontaneous Reporting of Suspected Renal Toxicity in Patients Undergoing Highly Active Anti-Retroviral Therapy in Two Public Health Facilities in UgandaDrug Safety201523
3. 3
   Drug safety in Africa: a review of systems and resources for pharmacovigilanceExpert Opinion on Drug Safety202321
4. 4
   Facilitators and Barriers to Uptake of the Med Safety Mobile App for Adverse Drug Reaction Reporting by Health Workers in Uganda: A Qualitative StudyDrug Safety202319
5. 5
   The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is NeededDrug Safety202313
6. 6
   The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs)Drug Safety20235
7. 7
   Advancing Pharmacovigilance Practice in Africa: Moving from Data Collection to Data-Driven Decision Making—Report from the 4th ISoP Africa Chapter MeetingDrug Safety20253
8. 8
   Correction: Advancing Pharmacovigilance Practice in Africa: Moving from Data Collection to Data-Driven Decision Making—Report from the 4th ISoP Africa Chapter MeetingDrug Safety20261

主要发表期刊

研究主题